BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 30844737)

  • 1. The persisting puzzle of racial disparity in triple negative breast cancer: looking through a new lens.
    Garlapati C; Joshi S; Sahoo B; Kapoor S; Aneja R
    Front Biosci (Schol Ed); 2019 Mar; 11(1):75-88. PubMed ID: 30844737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Analysis of Breast Cancer Phenotypes in African American, White American, and West Versus East African patients: Correlation Between African Ancestry and Triple-Negative Breast Cancer.
    Jiagge E; Jibril AS; Chitale D; Bensenhaver JM; Awuah B; Hoenerhoff M; Adjei E; Bekele M; Abebe E; Nathanson SD; Gyan K; Salem B; Oppong J; Aitpillah F; Kyei I; Bonsu EO; Proctor E; Merajver SD; Wicha M; Stark A; Newman LA
    Ann Surg Oncol; 2016 Nov; 23(12):3843-3849. PubMed ID: 27469125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome disparities in African American women with triple negative breast cancer: a comparison of epidemiological and molecular factors between African American and Caucasian women with triple negative breast cancer.
    Sturtz LA; Melley J; Mamula K; Shriver CD; Ellsworth RE
    BMC Cancer; 2014 Feb; 14():62. PubMed ID: 24495414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying Biomarkers Using Support Vector Machine to Understand the Racial Disparity in Triple-Negative Breast Cancer.
    Sahoo B; Pinnix Z; Sims S; Zelikovsky A
    J Comput Biol; 2023 Apr; 30(4):502-517. PubMed ID: 36716280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial Disparities in Triple Negative Breast Cancer: A Review of the Role of Biologic and Non-biologic Factors.
    Prakash O; Hossain F; Danos D; Lassak A; Scribner R; Miele L
    Front Public Health; 2020; 8():576964. PubMed ID: 33415093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen Receptor and ALDH1 Expression Among Internationally Diverse Patient Populations.
    Jiagge E; Jibril AS; Davis M; Murga-Zamalloa C; Kleer CG; Gyan K; Divine G; Hoenerhoff M; Bensenhave J; Awuah B; Oppong J; Adjei E; Salem B; Toy K; Merajver S; Wicha M; Newman L
    J Glob Oncol; 2018 Oct; 4():1-8. PubMed ID: 30307804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlates of Triple Negative Breast Cancer and Chemotherapy Patterns in Black and White Women With Breast Cancer.
    Sheppard VB; Cavalli LR; Dash C; Kanaan YM; Dilawari AA; Horton S; Makambi KH
    Clin Breast Cancer; 2017 Jun; 17(3):232-238. PubMed ID: 28189497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune microenvironment of triple-negative breast cancer in African-American and Caucasian women.
    O'Meara T; Safonov A; Casadevall D; Qing T; Silber A; Killelea B; Hatzis C; Pusztai L
    Breast Cancer Res Treat; 2019 May; 175(1):247-259. PubMed ID: 30725384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentially expressed miRNAs in triple negative breast cancer between African-American and non-Hispanic white women.
    Sugita B; Gill M; Mahajan A; Duttargi A; Kirolikar S; Almeida R; Regis K; Oluwasanmi OL; Marchi F; Marian C; Makambi K; Kallakury B; Sheahan L; Cavalli IJ; Ribeiro EM; Madhavan S; Boca S; Gusev Y; Cavalli LR
    Oncotarget; 2016 Nov; 7(48):79274-79291. PubMed ID: 27813494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in the mutational landscape of triple-negative breast cancer in African Americans and Caucasians.
    Ademuyiwa FO; Tao Y; Luo J; Weilbaecher K; Ma CX
    Breast Cancer Res Treat; 2017 Feb; 161(3):491-499. PubMed ID: 27915434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic analysis of racial differences in triple negative breast cancer.
    Chang CS; Kitamura E; Johnson J; Bollag R; Hawthorn L
    Genomics; 2019 Dec; 111(6):1529-1542. PubMed ID: 30366040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular profiling of a real-world breast cancer cohort with genetically inferred ancestries reveals actionable tumor biology differences between European ancestry and African ancestry patient populations.
    Miyashita M; Bell JSK; Wenric S; Karaesmen E; Rhead B; Kase M; Kaneva K; De La Vega FM; Zheng Y; Yoshimatsu TF; Khramtsova G; Liu F; Zhao F; Howard FM; Nanda R; Beaubier N; White KP; Huo D; Olopade OI
    Breast Cancer Res; 2023 May; 25(1):58. PubMed ID: 37231433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary Susceptibility for Triple Negative Breast Cancer Associated With Western Sub-Saharan African Ancestry: Results From an International Surgical Breast Cancer Collaborative.
    Newman LA; Jenkins B; Chen Y; Oppong JK; Adjei E; Jibril AS; Hoda S; Cheng E; Chitale D; Bensenhaver JM; Awuah B; Bekele M; Abebe E; Kyei I; Aitpillah F; Adinku M; Nathanson SD; Jackson L; Jiagge E; Merajver S; Petersen LF; Proctor E; Gyan KK; Martini R; Kittles R; Davis MB
    Ann Surg; 2019 Sep; 270(3):484-492. PubMed ID: 31356281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of SIRT1, SIRT3 and SIRT6 Genes for Predicting Survival in Triple-Negative and Hormone Receptor-Positive Subtypes of Breast Cancer.
    Uzelac B; Krivokuca A; Brankovic-Magic M; Magic Z; Susnjar S; Milovanovic Z; Supic G
    Pathol Oncol Res; 2020 Oct; 26(4):2723-2731. PubMed ID: 32681437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health Disparities and Triple-Negative Breast Cancer in African American Women: A Review.
    Newman LA; Kaljee LM
    JAMA Surg; 2017 May; 152(5):485-493. PubMed ID: 28355428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of microRNA between triple negative breast cancer patients of African American and European American descent.
    MacCuaig WM; Thomas A; Claros-Sorto JC; Gomez-Gutierrez JG; Alexander AC; Wellberg EA; Grizzle WE; McNally LR
    Biotech Histochem; 2022 Jan; 97(1):1-10. PubMed ID: 34979848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time will tell: Circadian clock dysregulation in triple negative breast cancer.
    Rida P; Syed MI; Aneja R
    Front Biosci (Schol Ed); 2019 Mar; 11(1):178-192. PubMed ID: 30844743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower frequency of TLR9 variant associated with protection from breast cancer among African Americans.
    Chandler MR; Keene KS; Tuomela JM; Forero-Torres A; Desmond R; Vuopala KS; Harris KW; Merner ND; Selander KS
    PLoS One; 2017; 12(9):e0183832. PubMed ID: 28886076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translational Epidemiology: An Integrative Approach to Determine the Interplay Between Genetic Ancestry and Neighborhood Socioeconomic Status on Triple Negative Breast Cancer.
    Goel N; Yadegarynia S; Kwon D; Kesmodel SB; Harbour JW; Kobetz E; Merchant N; Rodriguez DA
    Ann Surg; 2022 Sep; 276(3):430-440. PubMed ID: 35758508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy response and prognosis of patients with early breast cancer with low positivity for hormone receptors - An analysis of 2765 patients from neoadjuvant clinical trials.
    Villegas SL; Nekljudova V; Pfarr N; Engel J; Untch M; Schrodi S; Holms F; Ulmer HU; Fasching PA; Weber KE; Albig C; Heinrichs C; Marmé F; Hartmann A; Hanusch C; Schmitt WD; Huober J; Lederer B; van Mackelenbergh M; Tesch H; Jackisch C; Rezai M; Sinn P; Sinn BV; Hackmann J; Kiechle M; Schneeweiss A; Weichert W; Denkert C; Loibl S
    Eur J Cancer; 2021 May; 148():159-170. PubMed ID: 33743484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.